These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1192959)

  • 1. [Hemolytic disease of newborn].
    Speilmann W
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1918. PubMed ID: 1192959
    [No Abstract]   [Full Text] [Related]  

  • 2. [The exchange transfusion in hemolytic disease of the newborn due to ABO-incompatibility].
    Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):364-5. PubMed ID: 4193015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 4. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
    Kulich V; Sauer J
    Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement in ABO--hemolytic disease of the newborn.
    Wang MY; Desforges JF
    Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the blood serum examination for the presence of anti-ABO system antibodies in mothers of newborn infants with fetal erythroblastosis requiring exchange transfusion].
    Cwik J
    Pediatr Pol; 1988 Sep; 63(9):563-8. PubMed ID: 3253666
    [No Abstract]   [Full Text] [Related]  

  • 8. [ABO hemolytic disease of the newborn. Treatment by exsanguination transfusion].
    Lange MM
    Pathologica; 1972; 64(935):315-24. PubMed ID: 4677646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
    Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
    Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 12. [Icterus gravis and exchange transfusion].
    Tulzer W; Griebler T
    Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
    [No Abstract]   [Full Text] [Related]  

  • 13. [The rule of transfusional ABO compatibility in the neonatal period].
    Sender A; Maigret P; Poulain M; Boeswillwald M; Lepage F
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(5):560-1. PubMed ID: 5170679
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythropoietic activity in newborn infants with maternal-fetal incompatibility in the ABO system treated with exchange transfusion. Use of the Ashby method in 14 cases].
    Stegagno G; Mencarini L; Orvieto G
    Minerva Pediatr; 1968 Oct; 20(41):2131-42. PubMed ID: 5754726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Causes of regression in the exchange transfusion of newborn infants in Styria].
    Rosegger VH; Teubl I; Stern E; Müller WD; Haidvogl M
    Wien Med Wochenschr; 1978 May; 128(10):298-301. PubMed ID: 96610
    [No Abstract]   [Full Text] [Related]  

  • 17. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of AB substance for the exsanguination transfusion in ABO system incompatibility].
    Ruttkay F; Fabian P; Calkovská Z
    Cesk Pediatr; 1972 Nov; 27(11):554-5. PubMed ID: 4673826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
    Hodr R; Vondrácek J; Skutilová J
    Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.